Principaux concurrents
Rendement du dividende (Y) Rendement du dividende (Y+1) PER (Y) Price to Book (Y) VE / CA (Y) VE / EBITDA (Y) VE / EBIT (Y) Capi.($)
- - - - - - - 564 M
0,45%0,48%17.62x-41.94x0.21x12.24x12.83x 87,21 Md
0,93%0,94%28.68x-22.45x0.22x14.41x16.36x 52,17 Md
1,43%1,75%43.26x6.38x3.06x28.38x30.26x 22,25 Md
2,71%2,99%11.07x0.74x0.2x4.73x5.88x 7,96 Md
2,63%2,94%12.82x1.84x0.98x7.92x9.52x 7,45 Md
5,3%5,71%5.67x0.48x0.09x2.64x3.13x 6,49 Md
3,53%3,62%9.26x1.42x1.73x5.53x7.43x 6,17 Md
3,01%3,17%23.97x2.74x1.16x14.27x20.36x 5,19 Md
4,36%4,65%10.25x0.81x0.12x4.2x5.5x 3,53 Md
2,47%2,62%13.09x0.77x - - - 3,29 Md
3,21%3,51%9.75x1.02x - - - 3,02 Md
5,87%5,73%14.27x1.25x0.33x7.29x9.56x 2,43 Md
0,24%0,49%24.57x - 0.41x8.2x9.14x 2,46 Md
2,04%2,18%9.8x0.81x - - - 2,05 Md
2,82%2,51%10.71x0.65x0.17x5.34x6.42x 1,74 Md
3,16%4,74%14.22x0.92x - - - 1,52 Md
Moyenne 2,76% 3% 16,19x -2,97x 0,72x 9,60x 11,37x 12,68 Md
Moyenne pondérée par Capi. 1,37% 1,48% 21,69x -21,77x 0,62x 13,34x 14,69x
Vente en gros de produits pharmaceutiques
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT